http://www.epizyme.com
Epizyme, Inc. Company Intro
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Industry
Healthcare
Epizyme, Inc. Headquaters
400 Technology Square
Cambridge,02139
United States
Epizyme, Inc. Share price
28 Jan 2021 01:35 GMT
$11.65
-0.19 (-1.6 %)
Epizyme, Inc. Market cap
$1.198 B
WMC RANKING
2021
Epizyme, Inc. # 145
BiotechnologyLatest Epizyme, Inc. News
20 Jan 2021
Analyst Rating: Will Epizyme Inc (EPZM) Stock Outperform the ...
InvestorsObserver is giving Epizyme Inc (EPZM) an Analyst Rating Rank of 57, meaning EPZM is ranked higher by analysts than 57% of stocks. The average ...
20 Jan 2021
Global Synovial Sarcoma Treatment Market Analysis Reveals ...
The company profiles of all the key players and brands that are dominating the ... market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Epizyme, Inc., Cue ...
20 Jan 2021
Analyst Rating: Will Epizyme Inc (EPZM) Stock Outperform the ...
InvestorsObserver is giving Epizyme Inc (EPZM) an Analyst Rating Rank of 57, meaning EPZM is ranked higher by analysts than 57% of stocks. The average ...
WMC Market Score
WMC Market to Revenue Score
Epizyme, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Epizyme, Inc. | USD | $17,263 | $214,150 | $-191,893 | $11,980B | 145 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $550,130B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $340,530B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $585,740B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $263,140B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Epizyme, Inc. Social Followers vs Top 4 Industry Competitors
Epizyme, Inc. Post vs Top 4 Industry Competitors
Epizyme, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Epizyme, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Epizyme, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Epizyme, Inc. | 0.19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.55 | 10.99 | 100 | 0 | 0 | 93.89 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.60 | 100 | 60 | 0 | 0 | 93.45 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 3.26 | 86 | 0 | 0 | 100 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
